ExodusPoint Capital Management’s Mersana Therapeutics MRSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3K | Buy |
+457
| New | +$3K | ﹤0.01% | 1331 |
|
|
2025
Q1 | – | Sell |
-7,766
| Closed | -$278K | – | 1692 |
|
|
2024
Q4 | $278K | Buy |
+7,766
| New | +$278K | ﹤0.01% | 1186 |
|
|
2024
Q3 | – | Sell |
-4,287
| Closed | -$215K | – | 1779 |
|
|
2024
Q2 | $215K | Buy |
+4,287
| New | +$215K | ﹤0.01% | 1254 |
|
|
2023
Q2 | – | Sell |
-1,601
| Closed | -$165K | – | 2006 |
|
|
2023
Q1 | $165K | Buy |
1,601
+1,129
| +239% | +$116K | ﹤0.01% | 1500 |
|
|
2022
Q4 | $69K | Sell |
472
-5,824
| -93% | -$851K | ﹤0.01% | 1482 |
|
|
2022
Q3 | $1.06M | Buy |
6,296
+5,275
| +517% | +$891K | 0.01% | 1052 |
|
|
2022
Q2 | $118K | Sell |
1,021
-10,063
| -91% | -$1.16M | ﹤0.01% | 1678 |
|
|
2022
Q1 | $1.11M | Buy |
11,084
+9,868
| +812% | +$985K | 0.01% | 1029 |
|
|
2021
Q4 | $189K | Buy |
+1,216
| New | +$189K | ﹤0.01% | 1801 |
|
|
2021
Q3 | – | Sell |
-846
| Closed | -$287K | – | 2366 |
|
|
2021
Q2 | $287K | Buy |
+846
| New | +$287K | ﹤0.01% | 1697 |
|
|
2021
Q1 | – | Sell |
-1,308
| Closed | -$870K | – | 2354 |
|
|
2020
Q4 | $870K | Sell |
1,308
-490
| -27% | -$326K | 0.01% | 874 |
|
|
2020
Q3 | $837K | Buy |
+1,798
| New | +$837K | 0.02% | 712 |
|
|
2019
Q2 | – | Sell |
-2,180
| Closed | -$287K | – | 1231 |
|
|
2019
Q1 | $287K | Buy |
+2,180
| New | +$287K | 0.02% | 470 |
|